MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA)
Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA) Drug alert number: EL (22)A/50 Date issued: 05 December 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: MacroBID 100mg Prolonged-Release Capsules, PL 12762/0052 Batch Number Expiry Date Pack Size First Distributed 21001 05 [...]
The post MHRA Class 4 Medicines Defect Information: MacroBID 100mg Prolonged-Release Capsules (ADVANZ PHARMA) appeared first on PSNC Website.
Recent Comments